Capability for genome sequencing and variant calling has increased dramatically, enabling large scale genomic interrogation of human disease. However, discovery is hindered by the current limitations in genomic interpretation, which remains a complicated and disjointed process. We introduce Seave, a web platform that enables variants to be easily filtered and annotated with in silico pathogenicity prediction scores and annotations from popular disease databases. Seave stores genomic variation of all types and sizes, and allows filtering for specific inheritance patterns, quality values, allele frequencies and gene lists. Seave is open source and deployable locally, or on a cloud computing provider, and works readily with gene panel, exome and whole genome data, scaling from single labs to multi-institution scale.
Introduction
The falling cost of genome sequencing has enabled the sequencing of large cohorts of patients, to interrogate genomic variation and identify underlying causes of human disease. As a result, thousands of genes have been associated with disease, our understanding of genotype-phenotype correlations has significantly advanced, many bioinformatics tools have been developed and increasing complexity is being observed across the genome.
In medicine, there has been a rapid uptake of genome sequencing for gene discovery and diagnosis within the areas of rare disease, pharmacogenomics, non-invasive pre-natal screening and cancer care (Delaney et al. 2016) . Genomics allows the comprehensive identification of variation, ranging from short variants affecting several bases such as single nucleotide variants (SNVs) and short insertions or deletions (Indels), to large copy number variants (CNVs), structural variants (SVs) and chromosomal aneuploidy. However, for personalised medicine to become a reality, all genomic variation will need to be identified and integrated with current biological and clinical knowledge, in formats that are accessible to all researchers and clinicians.
Interpretation of genomic variation by researchers and clinicians remains a difficult task (Amendola et al. 2016) . Bioinformatics tools are designed to discover specific types of variation, ranging from point mutations to chromosomescale copy number changes and rearrangements. To be of value, the functional impact of all variants on their surrounding genes and other functional elements in the genome must be comprehensively reported. It is also increasingly important to merge variant types together to determine overlapping events causing disease, such as a combined structural variant impacting one allele and a nonsense variant on the other in an autosomal recessive disorder. Variant annotations such as in silico scores, population frequencies in healthy controls and disease-focussed databases (e.g. ClinVar, COSMIC) can inform the inferred functional impact of a variant on a gene to help predict either pathogenicity or benignancy; however, these annotations and scores are scattered across many databases, making investigating a list of variants a cumbersome process. Curating candidate gene lists related to different diseases or aspects of biology remains a standard way for investigators to restrict the genomic search space, however these require frequent updates to keep up with the ever growing literature.
To address these challenges, we developed Seave, a web-based variant filtration platform that stores, queries and annotates genomic variation of all sizes. Seave was developed from the ground up for whole genome scale data and thus handles targeted sequencing data with ease. Currently supported variant types include SNVs, Indels, CNVs, SVs and regions of homozygosity 3 (ROH). It is designed for clinicians and researchers and requires no knowledge of bioinformatics to use. Seave allows familial filtering on standard inheritance patterns using any combination of family members, and to easily edit the family structure to handle individuals with uncertain phenotype. Variants are annotated with a number of high quality databases and in silico prediction scores stored within Seave, with infrastructure to update these annotations over time.
Gene lists can be used to restrict the genomic search space and are stored and managed within Seave; an audit trail of every change is recorded. Seave features an account system with users and groups that allows sharing of data with only those who should access it. We highlight Seave's features and the flow of information during a typical analysis in Figure 1 . We believe our novel packaging of these features in an open source platform capable of storing and querying all sizes of genomic variation represents a significant contribution to making genomic data more accessible to those who have the biological knowledge to interpret it best.
Results
Seave was built at the Garvan Institute to enable gene discovery research, diagnostics and precision cancer medicine. It was predicated on a need to handle whole genome scale data and allow the flexibility to work with an everchanging suite of bioinformatics tools for a growing list of diseases. We found existing solutions to be incapable of scale and/or flexibility and opted to build an in-house platform allowing rapid feedback from clinicians, researchers and bioinformaticians. Seave is in widespread use in Australia by multiple research groups, within clinical trials, for clinical genomics training and commercially for diagnostics. in known genes and a further two diagnosed after relaxing the known disease gene list filter, leading to an expansion of the understanding of the phenotypic spectrum of mutations in GLB1 and PEX16 in this disease (Kumar et al. 2016) .
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These case studies were all enabled by Seave's inheritance filtering and rich annotations that allowed rapid discovery of known variants or gene impacts of novel variants.
Cancer Research
The comprehensive interpretation of somatic variation represents a significant 
Precision Cancer Genomics Clinical Trials
The 
Education & Training
Seave has been used for training purposes as part of the Kinghorn Centre for Clinical Genomics' commitment to improving genomics education. Three clinical genomics data analysis workshops with an average attendance of 60 practicing clinical geneticists, researchers, laboratory scientists and other health professionals have been run, both within Australia and internationally. Seave was extensively used to provide hands-on experience with interpreting genomic data. Particularly, inheritance filtering of variation from trios of patients provided a familiar starting point for clinicians to understand the power of genomics and how they can use it in practice. Seave was well-received and trainees found it quick and easy to use, even as cases grew progressively more complicated.
Discussion
Precision medicine promises improved patient outcomes and better understanding of disease biology and relies on accurate identification and prioriti- 
Methods
Analysis pipeline and importing data
Seave is a data exploration, annotation, filtration and interpretation tool and, as such, belongs at the end of a bioinformatics analysis pipeline. The primary input into Seave is short variants (SNVs and Indels) in the form of GEMINI (Talevich et al. 2016) ; these are imported using the unmodified outputs from each tool. We have found that even on a modest single core server, Seave scales well with databases containing variants with up to 123 whole genomes (22.3 million variants) and up to 252 exomes (3.1 million variants) for cohort-level analysis.
Querying short variants
Affected status specification GEMINI databases imported into Seave contain a fixed number of samples and short variants ( Supplementary Figure 1) . Seave allows classifying the samples into families, by their affected status and gender, either through a web form or pedigree file (.ped). This information is then used to enable variant filtering based on inheritance pattern in a variant-focussed manner ( Supplementary   Figure 2 ). For example, given a family with a rare disease where any number of individuals have been sequenced, a variant-focussed approach will attempt to find variants that are shared within the affected individuals in the family but not present in the unaffected individuals with the expected severity. Individuals with uncertain affected status can be easily added or removed from the family. This approach foregoes strict specification of pedigrees and is fluid to the reality of the difficulty in obtaining samples and high sequencing costs.
Inheritance patterns and families
We have implemented the standard mendelian inheritance patterns of heterozygous dominant, homozygous recessive, de novo dominant and compound heterozygous. Each inheritance pattern filter utilises the affected status of samples within a family to identify putative causative variants. Other inheritance patterns such as X-linked recessive can be constructed as needed, for example, by using the homozygous recessive pattern and restricting variants to chromo-13 some X.
While a database may contain a cohort of individuals, grouping these into one or more families allows restricting sample-specific information returned to just the family selected. Combining variants from multiple families into one database allows information about variant prevalence in the cohort to be returned even when variants in just one family have been requested.
Filtering
After optionally selecting a family and inheritance pattern, the primary filtration happens on the query page ( Supplementary Figure 3) . the type and maximum number of variants returned can be restricted. Using the information specified, Seave creates SQL queries used to run GEMINI on the database. Queries typically take seconds to execute but this can stretch up to a minute for cohorts of genomes with inheritance patterns specified.
Variant counts
A typical family trio sequenced by whole genome sequencing contains approximately 6 million short variants, however, this number is rapidly reduced when just a few of the filtration criteria described are applied. Figure 2 shows 
Results and annotations
The results of a query are displayed on the results page in a dynamic table that includes all variants and annotations ( Supplementary Figure 4) . Default columns provide a summary of each variant and its impact on the genome, while individual annotation sources can be shown alongside by clicking buttons below the table (Supplementary Figure 5) . The default Impact Summary column combines the major annotations into a single set of coloured icons de- Figure 2 : Variant counts from whole genome sequencing in the NA12878 trio restricted by combinations of rarity, gene impact (damaging) and inheritance patterns. Counts derived using the best practices GATK pipeline on raw data from the Illumina Platinum Genomes project (Eberle et al. 2017 ), mapped to the b37+decoy reference genome, decomposed and normalised with vt (Tan et al. 2015) and queried with GEMINI (Paila et al. 2013) . Rarity is defined as a maximum allele frequency of 1% in 1000 Genomes, ExAC and ESP. Impact is defined as medium or high impact, as defined by the Ensembl impact variant annotation. *NA12878 and NA12891 were marked as affected for the purposes of this analysis. **NA12878 was marked as affected for the purposes of this analysis.
noting whether each annotation classifies the variant as pathogenic (red), benign (white) or does not contain any information (grey). Where an annotation source has an external web resource for the variant or gene, a link is provided that takes the user to the record, for example, clicking the genomic coordi- let them see the same results page but without the ability to further query the database. Finally, all query options are saved so re-running analyses with modified parameters or inheritance models is a rapid process.
Querying long variants
The Genome Block Store (GBS) within Seave stores long variants such as copy number variants, structural variants and losses of heterozygosity. GBS data can be queried either independently of short variants to explore the impact of just these events on the genome, or in conjunction with short variants to find sites of multiple hits. Similarly to short variants, GBS data is queried by families and samples, and several analysis types are available to explore the large variation in different ways. The GBS uses sample names to tie short variants to long variants and partially relies on BEDTools (Quinlan and Hall 2010) to perform interval querying logic.
Coordinate and gene list query
Querying by gene lists or genomic coordinates is the most common way to subset large variants to genomic regions with potential clinical impact. For example, a sample with a deletion spanning a gene of known disease association can be detected by querying the sample in the GBS for a gene list containing the gene. The tabular results from this query type contain rows for each gene or coordinate overlap associated with a separate large variant and sample.
Structural variant fusions query
The SV fusions analysis type interrogates translocation and inversion events that interrupt normal transcripts by fusing a gene to a distant genomic location.
The breakpoints of these events are stored as linked blocks in the GBS and this analysis type finds all pairs of breakpoints where at least one is inside a gene of interest. The tabular results contain one fusion per row, called by a method for a sample, and include the gene(s) impacted along with the coordinates and annotations for each breakpoint.
Regions of homozygosity query
The GBS can store large regions of homozygosity identified by our in-house tool ROHmer (Puttick et al, manuscript in preparation). The ROHmer GBS analysis type identifies genomic regions of homozygosity that are shared by all affected individuals in a family but not shared by any unaffected individuals. These regions can be used to restrict the genomic search space to identify homozygous recessive variants that are the products of consanguinity.
Overlapping blocks query
Many groups run more than one CNV or SV caller, so the GBS allows the identification of all blocks that overlap between methods for the same sample. This is useful for determining regions of concordance between multiple variant callers. The GBS also allows finding overlapping blocks between samples for the same method which is useful for determining where multiple samples have shared variants called using the same method.
Short variants inside long variants
If a sample has both short variants and long variants in the GBS, they are automatically linked and returned in the short variant query results. This allows inferring second hit events such as a deletion combined with a damaging short variant or an inherited germline variant that has been duplicated to result in a gain of function. Seave does not currently include long variants during inheritance filtering so query results must be interpreted in light of Mendelian in-heritance, e.g. a heterozygous short variant will become homozygous if there is an overlapping deletion and will no longer be returned for a heterozygous dominant inheritance filter.
Somatic analyses
While Seave was initially created for germline rare disease analyses, it has been successfully used to interrogate somatic variants from multiple types of cancer sequencing using panels and whole genomes. Somatic variants called by Strelka (Saunders et al. 2012) or VarDict (Lai et al. 2016) have been used to create GEMINI (Paila et al. 2013) We recommend that the germline and all tumour samples from the same patient are grouped into a single family, and that inheritance filters are skipped, to ignore the zygosity of any variant. The ability to group multiple samples together allows the investigation of changes in variants across multiple sites or through time within a single patient. We highlight variant allele frequency (VAF) instead of genotype when comparing across samples, using the overlapping CNVs and the purity estimate to infer clonality changes. Linking short and long variants allows rapidly inferring the mechanism by which a given somatic short variant has gained a foothold within the sample.
Gene list management
Seave contains a custom gene list management system. Gene lists are uniquely named and have any number of genes associated with them. Upon addition to a gene list, all gene symbols are validated against a list of genes that can possibly be in Seave, based on the bioinformatics pipeline utilised. We recommend updating this list to the corresponding cache utilised by the version of VEP or snpEFF used to annotate VCFs input into Seave. We include the genes from the Ensembl 75 release, as this is the last to map to the b37 reference genome. Gene lists are available to all users within Seave for short and long variant query and can be modified at any time by administrators. We provide code for updating and tracking annotations within Seave as they develop over time, which we run on a monthly basis.
Variant annotations and updates
Data and user management
Seave caters to collaborative projects with a user and group management system. Variant data belongs to a group, and any number of users can belong to any number of groups. This makes segregating access to any given data set simple and shows every user all the data they have access to in one place. Administrator users are granted access to manipulate users, groups, variant data and gene lists in the administrator interface. All queries and changes to any aspect of Seave are logged for the purpose of keeping an audit trail.
Deployment via AWS
To reduce the installation burden of Seave, we have created an Amazon Machine Image (AMI) that can be used to create a Seave server on Amazon Web Services (AWS) with ease. The AMI has been preconfigured to contain all dependencies that Seave requires and allows researchers to provision a server with desired specifications to match their needs. We recommend a t2.micro instance for a single group using Seave and a c4.large instance or above for an institution-scale Seave. AWS allows users to dynamically adjust resources if the workload changes or as the amount of data grows and provides simple administration options that allow encrypting genomic data and firewalling access to Seave to trusted IP ranges. By default, Seave is set up to run entirely on one server which includes an Apache webserver, MySQL database and space for a genomic data store. Alternatively, genomic data can be stored on an encrypted AWS Elastic Block Store (EBS) volume mounted on the Seave 21 webserver and the MySQL database can be run on a dedicated AWS Relational Database Service (RDS) instance. A configuration file allows pointing the webserver to alternate locations easily, to the point where Seave can even be run locally.
Testing and automation
Seave is developed using standard software engineering practices. Code development proceeds using continuous integration via git with automated testing and fixed deployments to various staging servers. Seave includes an end-toend testing framework powered by Selenium which automatically performs a suite of variant queries on every code push and branch merge, to compare
the results with what is expected and ensure no change to the code base has altered the results returned. We recommend those wishing to modify Seave to make use of these practices and contribute improvements back to the public repository via pull requests.
Availability and licensing
To demo Seave with public data, navigate to: https://www.seave.bio. Seave is licensed exclusively for research or training use and the source code is avail- 
